Metabolic crossroads in insulin resistance: exploring lipid dysregulation and inflammation.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic literature without new empirical data or systematic search methods.
PubMed 41376626 · doi:10.3389/fimmu.2025.1692742
What was done
The authors synthesized literature on the mechanistic links between lipid dysregulation, chronic low-grade inflammation, and insulin resistance across conditions such as obesity, type 2 diabetes, polycystic ovary syndrome, and cardiovascular disease, focusing on PI3K/Akt, AMPK, and JNK signaling pathways and bioactive lipid intermediates like diacylglycerols and ceramides.
What was found
No empirical numbers or statistics are reported in the abstract. The review outlines a reciprocal cycle in which bioactive lipid intermediates promote lipotoxicity and trigger inflammatory cascades, while inflammatory cytokines and adipokines further impair insulin receptor function and aggravate metabolic stress.
Why it matters
The paper synthesizes how inflammatory and lipid pathways intersect to maintain insulin resistance, identifying shared signaling nodes for metabolic disease research.
Limits
Narrative review format with no primary experimental data, clinical outcomes, or systematic literature search reported in the abstract. Key knowledge gaps identified include tissue-specific effects, pathway interactions, sex-based differences, and uncharacterized lipid species.
Cited by
- supports Adipose accumulation is inflammatory, creating a bidirectional vicious cycle that exacerbates insulin resistance.